The data for VAXINIA was excellent given they are early in Ph1 clinical trial but there's not enough released yet. Do you think PH will block JV or partnership deal from BP for IP early in their development stage as they are consider "cheap" value to him????
- Forums
- ASX - By Stock
- Media Thread
IMU
imugene limited
Add to My Watchlist
3.57%
!
27.0¢

The data for VAXINIA was excellent given they are early in Ph1...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.0¢ |
Change
-0.010(3.57%) |
Mkt cap ! $77.89M |
Open | High | Low | Value | Volume |
28.0¢ | 28.0¢ | 26.3¢ | $1.990M | 7.367M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 209631 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.270 |
23 | 459703 | 0.265 |
29 | 541017 | 0.260 |
10 | 198736 | 0.255 |
28 | 465132 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 159631 | 8 |
0.280 | 35445 | 6 |
0.285 | 162388 | 4 |
0.290 | 216868 | 4 |
0.295 | 10000 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online